Search

everythinglearnresearchcommunity

for

Search:↓

The article concludes that better diagnosis and management of Polycystic Ovarian Syndrome are needed to improve women's health and prevent related diseases.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Androgens increase EPO production, finasteride doesn't significantly impact it.

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

Some skin diseases and their treatments can negatively affect male fertility.

Finasteride and methadone don't increase advanced liver disease risk in HCV+ male veterans.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Wnt signaling is vital for cell growth, development, and cancer research.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Eating less sugar, milk, and saturated fats and more vegetables and fish may help treat and prevent acne.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Lower levels of certain brain chemicals are linked to worse PTSD symptoms in men.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

A woman with breast cancer developed a rare condition causing excessive fine hair growth on her face and body.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

The research suggests that the ZP4 gene is linked to egg development in women with PCOS but requires more study to understand its role in infertility.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

PCOS is a long-term condition that needs more research for better understanding and treatment.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.